Disease modification in migraine: Study design and sample size implications

Headache

Volumn 48, Issue 8, 2008, Pages 1169-1175

  Fox, Anthony W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EBD Group   (United States)

Author keywords

Clinical trial; Disease modification; Migraine; Model

Indexed keywords

ANTIMIGRAINE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; FOLLOW UP; HUMAN; METHODOLOGY; MIGRAINE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLINICAL TRIALS AS TOPIC; DRUG THERAPY, COMBINATION; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUESTIONNAIRES; RESEARCH DESIGN; SAMPLE SIZE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TRYPTAMINES; UNITED STATES;

EID: 51249094886     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2007.01057.x     Document Type: Article

References (11)

1. Newman L, Mannix LK, Landy S, et al. Naratriptan as short-term prophylaxis of menstrually-associated migraine: A randomized, double-blind, placebo-controlled study. Headache. 2001 41 : 248 256.
2. Brandes JL, Smith T, Diamond M, Ames MH. Open-label, longterm tolerability of naratriptan for short-term prevention of menstrually-related migraine. Headache. 2007 47 : 886 894.
3. Silberstein S, Elkind AH, Schreiber C, Keywood C. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology. 2004 63 : 261 269.
4. Mathew NT, Stubits E, Nigam MP. Transformation of episodic migraine into daily headache: Analysis of factors. Headache. 1982 22 : 66 68.
5. Post RM, Silberstein SD. Shared mechanisms in affective illness, epilepsy, and migraine. Neurology. 1994 44 (Suppl 7 S37 S47.
6. Post RM. Do the epilepsies, pain syndromes, and affective disorders share common kindling-like mechanisms. Epilepsy Res. 2002 50 : 203 219.
7. van der Kuy PH, Lohman JJ. A quantification of the placebo response in migraine prophylaxis. Cephalalgia. 2002 22 : 265 270.
8. Tomkins GE, Jackson JL, O'Malley PG, Balden E, Santoro GE. Treatment of chronic headache with antidepressants: A meta-analysis. Am J Med. 2001 111 : 45 63.
9. Holroyd KA, Penzien DB, Cordingley GE. Propranolol in the management of recurrent migraine: A meta-analytic review. Headache. 1991 31 : 333 340.
10. Gore SM. Statistical considerations. In : Burley DM, Binns TB, eds. Pharmaceutical Medicine. London : Edward Arnold 1985 : 117 118.
11. Fleiss JL, Levin B, Paik MC. Determining sample sizes needed to detect a difference between two proportions. In : Fleiss JL, Levin B, Paik MC, eds. Statistical Methods for Rates and Proportions. Third edn. Hoboken, NJ : John. Wiley & Sons 2003 : 69 73.